These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6833751)

  • 1. Genetic control of low-dose streptozotocin-induced autoimmune diabetes in mice.
    Kiesel U; Falkenberg FW; Kolb H
    J Immunol; 1983 Apr; 130(4):1719-22. PubMed ID: 6833751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of toxicokinetics on murine mercury-induced autoimmunity.
    Hultman P; Nielsen JB
    Environ Res; 1998 May; 77(2):141-8. PubMed ID: 9600807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic control by I-A subregion in H-2 complex of incidence of streptozocin-induced autoimmune diabetes in mice.
    Tanaka S; Nakajima S; Inoue S; Takamura Y; Aoki I; Okuda K
    Diabetes; 1990 Oct; 39(10):1298-304. PubMed ID: 2145188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic control of susceptibility to experimental autoimmune uveoretinitis in the mouse model. Concomitant regulation by MHC and non-MHC genes.
    Caspi RR; Grubbs BG; Chan CC; Chader GJ; Wiggert B
    J Immunol; 1992 Apr; 148(8):2384-9. PubMed ID: 1560198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations in the susceptibility to Coxsackievirus B3-induced myocarditis among different strains of mice.
    Wolfgram LJ; Beisel KW; Herskowitz A; Rose NR
    J Immunol; 1986 Mar; 136(5):1846-52. PubMed ID: 3005402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-gamma induces islet cell MHC antigens and enhances autoimmune, streptozotocin-induced diabetes in the mouse.
    Campbell IL; Oxbrow L; Koulmanda M; Harrison LC
    J Immunol; 1988 Feb; 140(4):1111-6. PubMed ID: 2963859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of dose, gender, and non-H-2 genes in murine mercury-induced autoimmunity.
    Hultman P; Nielsen JB
    J Autoimmun; 2001 Aug; 17(1):27-37. PubMed ID: 11488635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose streptozotocin-induced autoimmune diabetes is under the genetic control of the major histocompatibility complex in mice.
    Kiesel U; Kolb H
    Diabetologia; 1982 Jul; 23(1):69-71. PubMed ID: 6214445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and immune response to islet antigens following treatment with low doses of streptozotocin in H-2d mice.
    Herold KC; Baumann E; Vezys V; Buckingham F
    J Autoimmun; 1997 Feb; 10(1):17-25. PubMed ID: 9080296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inheritance of tolerance susceptibility to human gamma-globulin in congenic mice.
    Ranges GE; Azar MM
    J Immunol; 1979 Sep; 123(3):1151-4. PubMed ID: 89162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H-2-controlled genetic susceptibility to pulmonary adenomas induced by urethane and 4-nitroquinoline 1-oxide in A/Wy congenic strains.
    Miyashita N; Moriwaki K
    Jpn J Cancer Res; 1987 May; 78(5):494-8. PubMed ID: 3112061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of low-dose streptozotocin-induced diabetes in ICAM-1-deficient mice.
    Martin S; Vinke A; Heidenthal E; Schulte B; van den Engel N
    Horm Metab Res; 1999 Dec; 31(12):636-40. PubMed ID: 10668914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic expression of interleukin 10 in the pancreas renders resistant mice susceptible to low dose streptozotocin-induced diabetes.
    Mueller R; Lee MS; Sawyer SP; Sarvetnick N
    J Autoimmun; 1996 Apr; 9(2):151-8. PubMed ID: 8738958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The radical scavenger edaravone counteracts diabetes in multiple low-dose streptozotocin-treated mice.
    Fukudome D; Matsuda M; Kawasaki T; Ago Y; Matsuda T
    Eur J Pharmacol; 2008 Mar; 583(1):164-9. PubMed ID: 18291360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic control of pathogenesis of diabetes in C3H mice. Influence of the major histocompatibility complex.
    Leiter EH
    Diabetes; 1984 Nov; 33(11):1068-71. PubMed ID: 6500186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciamexon in the low dose streptozotocin induced diabetes of mice.
    Linn T; Volkmann A; Germann H; Woehrle M; Bretzel RG; Bicker U; Federlin K
    Diabetes Res; 1987 Nov; 6(3):113-7. PubMed ID: 3325216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic control of susceptibility to streptozotocin diabetes in inbred mice: effect of testosterone and H-2 haplotype.
    Le PH; Leiter EH; Leyendecker JR
    Endocrinology; 1985 Jun; 116(6):2450-5. PubMed ID: 3888611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cyclosporin A on low-dose streptozotocin diabetes in mice.
    Kolb H; Oschilewski M; Schwab E; Oschilewski U; Kiesel U
    Diabetes Res; 1985 Jul; 2(4):191-3. PubMed ID: 3910327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental murine hypersensitivity pneumonitis: multigenic control and influence by genes within the I-B subregion of the H-2 complex.
    Wilson BD; Sternick JL; Yoshizawa Y; Katzenstein AL; Moore VL
    J Immunol; 1982 Nov; 129(5):2160-3. PubMed ID: 6811659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1 promotes hyperglycemia and insulitis in mice normally resistant to streptozotocin-induced diabetes.
    Zunino SJ; Simons LF; Sambrook JF; Gething MJ
    Am J Pathol; 1994 Sep; 145(3):661-70. PubMed ID: 8080048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.